Stivarga works by blocking the action of a variety of kinases. Kinases are naturally occurring proteins in the body that help regulate many cellular functions, including cell growth. In addition to their role in normal cell function, kinases also tell cancer cells to grow and divide. By blocking the action of these kinases, Stivarga can slow down or stop the growth of cancer cells.
Stivarga is not approved for use in individuals younger than 18 years of age, as it has not been adequately studied in this age group. Talk with your child's healthcare provider about the particular risks and benefits of using this medication in children.
Older adults can use Stivarga. In clinical studies, there were no differences in how Stivarga was tolerated, or how well it worked, between older adults and younger individuals.
On occasion, your healthcare provider may recommend this medicine for something other than the use discussed in this article. This is called an "off-label" use. At this time, there are no well-accepted off-label uses for Stivarga.